✦ LIBER ✦

Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: A Combined RESEARCH and T-SEARCH Long-Term Analysis

✍ Scribed by Marco Valgimigli; Patrizia Malagutti; Jiro Aoki; Héctor M. Garcia-Garcia; Gaston A. Rodriguez Granillo; Carlos A.G. van Mieghem; Jurgen M. Ligthart; Andrew T.L. Ong; George Sianos; Evelyn Regar; Ron T. Van Domburg; Pim De Feyter; Peter de Jaegere; Patrick W. Serruys

Book ID: 119265527
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 304 KB
Volume: 47
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2005.09.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Clinical Outcomes of Sirolimus

Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronary Artery Disease: Analysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry

✍ Jong-Young Lee; Duk-Woo Park; Sung-Cheol Yun; Seung-Whan Lee; Young-Hak Kim; Che 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Comparison of Long-Term Efficacy of the

Comparison of Long-Term Efficacy of the Paclitaxel-Eluting Stent Versus the Bare-Metal Stent for Treatment of Unprotected Left Main Coronary Artery Disease

✍ Yaling Han; Shouli Wang; Quanmin Jing; Yi Li; Haiwei Liu; Yingyan Ma; Zulu Wang; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Impact of drug-eluting stent selection o

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

✍ E. Meliga; H.M. Garcia-Garcia; M. Valgimigli; A. Chieffo; G. Biondi-Zoccai; A.O. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 282 KB

DRUG-ELUTING STENTS FOR THE TREATMENT OF

DRUG-ELUTING STENTS FOR THE TREATMENT OF LEFT MAIN CORONARY ARTERY DISEASE WITH SIROLIMUS, PACLITAXEL, ZOTAROLIMUS, BIOLIMUSA9, EPC CAPTURE AND EVEROLIMUS-ELUTING STENT: MULTICENTER REGISTRY IN ASIA

✍ Nakamura, Sunao; Nakamura, Shotaro; Ogawa, Hisao; Bae, Jang-Ho; Cahyadi, Yeo Han 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 73 KB

TCT-30: Drug-Eluting Stents for the Trea

TCT-30: Drug-Eluting Stents for the Treatment of Left Main coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, BiolimusA9, EPC Capture and Everolimus-Elutting Stent: Multicenter Registry in Asia

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Incidence, Predictors, Treatment, and Lo

Incidence, Predictors, Treatment, and Long-Term Prognosis of Patients With Restenosis After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease

✍ Jong-Young Lee; Duk-Woo Park; Young-Hak Kim; Sung-Cheol Yun; Won-Jang Kim; Soo-J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 967 KB